Chi-Ming Leung1,2, Dinghua Li3, Yan Xin3,4, Wai-Chun Law4, Yifan Zhang3,4, Hing-Fung Ting3, Ruibang Luo3,4, Tak-Wah Lam3,4. 1. Department of Computer Science, The University of Hong Kong, Pokfulam Road, Hong Kong, Hong Kong. cmleung2@cs.hku.hk. 2. L3 Bioinformatics Limited, Rm 2114, Hong Kong Plaza, 188 Connaught Road West, Sai Ying Pun, Hong Kong. cmleung2@cs.hku.hk. 3. Department of Computer Science, The University of Hong Kong, Pokfulam Road, Hong Kong, Hong Kong. 4. L3 Bioinformatics Limited, Rm 2114, Hong Kong Plaza, 188 Connaught Road West, Sai Ying Pun, Hong Kong.
Abstract
BACKGROUND: Next-generation sequencing (NGS) enables unbiased detection of pathogens by mapping the sequencing reads of a patient sample to the known reference sequence of bacteria and viruses. However, for a new pathogen without a reference sequence of a close relative, or with a high load of mutations compared to its predecessors, read mapping fails due to a low similarity between the pathogen and reference sequence, which in turn leads to insensitive and inaccurate pathogen detection outcomes. RESULTS: We developed MegaPath, which runs fast and provides high sensitivity in detecting new pathogens. In MegaPath, we have implemented and tested a combination of polishing techniques to remove non-informative human reads and spurious alignments. MegaPath applies a global optimization to the read alignments and reassigns the reads incorrectly aligned to multiple species to a unique species. The reassignment not only significantly increased the number of reads aligned to distant pathogens, but also significantly reduced incorrect alignments. MegaPath implements an enhanced maximum-exact-match prefix seeding strategy and a SIMD-accelerated Smith-Waterman algorithm to run fast. CONCLUSIONS: In our benchmarks, MegaPath demonstrated superior sensitivity by detecting eight times more reads from a low-similarity pathogen than other tools. Meanwhile, MegaPath ran much faster than the other state-of-the-art alignment-based pathogen detection tools (and compariable with the less sensitivity profile-based pathogen detection tools). The running time of MegaPath is about 20 min on a typical 1 Gb dataset.
BACKGROUND: Next-generation sequencing (NGS) enables unbiased detection of pathogens by mapping the sequencing reads of a patient sample to the known reference sequence of bacteria and viruses. However, for a new pathogen without a reference sequence of a close relative, or with a high load of mutations compared to its predecessors, read mapping fails due to a low similarity between the pathogen and reference sequence, which in turn leads to insensitive and inaccurate pathogen detection outcomes. RESULTS: We developed MegaPath, which runs fast and provides high sensitivity in detecting new pathogens. In MegaPath, we have implemented and tested a combination of polishing techniques to remove non-informative human reads and spurious alignments. MegaPath applies a global optimization to the read alignments and reassigns the reads incorrectly aligned to multiple species to a unique species. The reassignment not only significantly increased the number of reads aligned to distant pathogens, but also significantly reduced incorrect alignments. MegaPath implements an enhanced maximum-exact-match prefix seeding strategy and a SIMD-accelerated Smith-Waterman algorithm to run fast. CONCLUSIONS: In our benchmarks, MegaPath demonstrated superior sensitivity by detecting eight times more reads from a low-similarity pathogen than other tools. Meanwhile, MegaPath ran much faster than the other state-of-the-art alignment-based pathogen detection tools (and compariable with the less sensitivity profile-based pathogen detection tools). The running time of MegaPath is about 20 min on a typical 1 Gb dataset.
Authors: Alexander L Greninger; Samia N Naccache; Kevin Messacar; Anna Clayton; Guixia Yu; Sneha Somasekar; Scot Federman; Doug Stryke; Christopher Anderson; Shigeo Yagi; Sharon Messenger; Debra Wadford; Dongxiang Xia; James P Watt; Keith Van Haren; Samuel R Dominguez; Carol Glaser; Grace Aldrovandi; Charles Y Chiu Journal: Lancet Infect Dis Date: 2015-03-31 Impact factor: 25.071
Authors: Robert Schlaberg; Charles Y Chiu; Steve Miller; Gary W Procop; George Weinstock Journal: Arch Pathol Lab Med Date: 2017-02-07 Impact factor: 5.534
Authors: Gilda Grard; Joseph N Fair; Deanna Lee; Elizabeth Slikas; Imke Steffen; Jean-Jacques Muyembe; Taylor Sittler; Narayanan Veeraraghavan; J Graham Ruby; Chunlin Wang; Maria Makuwa; Prime Mulembakani; Robert B Tesh; Jonna Mazet; Anne W Rimoin; Travis Taylor; Bradley S Schneider; Graham Simmons; Eric Delwart; Nathan D Wolfe; Charles Y Chiu; Eric M Leroy Journal: PLoS Pathog Date: 2012-09-27 Impact factor: 6.823
Authors: Gordon M Daly; Richard M Leggett; William Rowe; Samuel Stubbs; Maxim Wilkinson; Ricardo H Ramirez-Gonzalez; Mario Caccamo; William Bernal; Jonathan L Heeney Journal: PLoS One Date: 2015-06-22 Impact factor: 3.240